title: Letter to the editor regarding "A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer" by Yaal-Hahoshen et al. (The Oncologist 2011;16:1197-1202).
authors.forename: Kim D
authors.initials: KD
authors.lastname: Mooiman
authors.forename: Andrew K L
authors.initials: AK
authors.lastname: Goey
authors.forename: Irma
authors.initials: I
authors.lastname: Meijerman
authors.forename: Jos H
authors.initials: JH
authors.lastname: Beijnen
authors.forename: Jan H M
authors.initials: JH
authors.lastname: Schellens
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000097:blood* / Q000188:drug therapy*; D005260:Female; D006402:Hematologic Diseases / Q000139:chemically induced* / Q000517:prevention & control*; D006801:Humans; D008517:Phytotherapy; D028321:Plant Preparations / Q000627:therapeutic use*
chemical_list: D028321:Plant Preparations